Korro Bio, Inc.: KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...
eLife13d
Action mechanism of a novel agrichemical quinofumelin against Fusarium graminearum
According to the latest information released by the Fungicide Resistance Action Committee (FRAC), over 30 fungicide selective targets have been identified and acknowledged in the field of fungicide ...
C&EN17d
Structural and Functional Insights into Targeting GCCG Sites in the EGFR Promoter by Two DNA Intercalators to Inhibit Breast Cancer Metastasis
Graduate Institute of Biotechnology, National Chung Hsing University, Taichung 402, Taiwan Graduate Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung 402, Taiwan ...
Frontiers18d
Genetic characterization of an H3N2 canine influenza virus strain in China in 2023—acquisition of novel human-like amino acid substitutions
We generated single-codon alignments ... PQ374169. Table 2. Nucleotide similarity analysis of H3N2 CIV. Sequence analysis of CIV-CC23 compared to the strains with the highest nucleotide similarity ...